Current treatment strategies for vitreomacular traction and macular holes: a survey of retinal specialists in Germany

被引:0
|
作者
Vogt, D. [1 ]
Haritoglou, C. [2 ]
Nicoletti, V. [1 ]
Kortuem, F. C. [3 ]
Deiters, V. [4 ]
Hoerauf, H. [5 ]
Wolf, A. [1 ]
Schumann, R. G. [1 ,6 ]
机构
[1] Univ Klinikum Ulm, Klin Augenheilkunde, Prittwitzstr 43, D-89075 Ulm, Germany
[2] Augenklin Herzog Carl Theodor, Munich, Germany
[3] Univ Klinikum Tubingen, Augenklinik, Tubingen, Germany
[4] Ludwig Maximilians Univ Munchen, Augenklin Univ Munchen, Munich, Germany
[5] Univ Med Gottingen, Augenklinik, Gottingen, Germany
[6] Augenzentrum & Gefassmed Munchen Schwabing, Munich, Germany
来源
OPHTHALMOLOGIE | 2024年 / 121卷 / 12期
关键词
Macular hole; Vitrectomy; Vitreolysis; Vitreomacular traction; Ocriplasmin; PARS-PLANA VITRECTOMY; PNEUMATIC VITREOLYSIS; OCRIPLASMIN;
D O I
10.1007/s00347-024-02118-1
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: To evaluate the different treatment strategies for eyes with vitreomacular traction (VMT) and macular holes (MF) regarding the indications and initiation of treatment. ObjectiveThe aim of this study is to facilitate clinical decision making by presenting the opinions of experienced retinal specialists in the context of the current literature and the changed approval situation for ocriplasmin. Material and methods: Members of the German Retina Society (RG) were questioned in an online survey. Based on a literature review a 100-question questionnaire was created and sent to all members of the RG via an electronic link to the online platform "LimeSurvey". Voluntary participation was possible from 15 October 2021 to 15 November 2021. Data collection and statistical analysis were anonymized. Results: The responses of the 115 participants were congruent with the presentation of the new S1 guidelines on this topic. The indications for active treatment of focal VMT without MF were postponed in favor of watchful waiting, with the individual symptoms of the patient playing a major role in the proposed temporal management. The results on the indications for vitrectomy are consistent and convincingly confirm the opinions on the efficacy and risk assessment of this therapeutic procedure. Conclusion: The results presented provide an overview of the consensus and controversies in the current treatment options for VMT and MF. With the help of a homogeneous and experienced group of retinal experts, it was possible to develop individual treatment strategies.
引用
收藏
页码:973 / 984
页数:12
相关论文
共 48 条
  • [41] Clinical practice pattern in management of diabetic macular edema in Japan: survey results of Japanese retinal specialists
    Yuichiro Ogura
    Fumio Shiraga
    Hiroko Terasaki
    Masahito Ohji
    Susumu Ishida
    Taiji Sakamoto
    Akito Hirakata
    Tatsuro Ishibashi
    Japanese Journal of Ophthalmology, 2017, 61 : 43 - 50
  • [42] Application of subretinal fluid to close refractory full thickness macular holes: treatment strategies and primary outcome: APOSTEL study
    Carsten H. Meyer
    Peter Szurman
    Christos Haritoglou
    Mathias Maier
    Armin Wolf
    Lyubomyr Lytvynchuk
    Siegfried Priglinger
    Jost Hillenkamp
    Joachim Wachtlin
    Matthias Becker
    Stefan Mennel
    Michael J. Koss
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2020, 258 : 2151 - 2161
  • [43] Current practice in the management of branch retinal vein occlusion in Japan: Survey results of retina specialists in Japan
    Ogura, Yuichiro
    Kondo, Mineo
    Kadonosono, Kazuaki
    Shimura, Masahiko
    Kamei, Motohiro
    Tsujikawa, Akitaka
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2019, 63 (05) : 365 - 373
  • [44] Pars Plana Vitrectomy and Silicone Oil Tamponade as a Primary Treatment for Retinal Detachment Caused by Macular Holes in Highly Myopic Eyes: A Risk-Factor Analysis
    Xie, Anming
    Lei, Jianqin
    CURRENT EYE RESEARCH, 2013, 38 (01) : 108 - 113
  • [45] Makulaschichtforamen – im Zentrum der vitreomakulären GrenzflächenerkrankungenPathophysiologie, Spontanverläufe und TherapiekonzepteLamellar macular holes—In the center of vitreomacular interface diseasesPathophysiology, spontaneous courses and treatment concepts
    Julian E. Klaas
    Albrecht Lommatzsch
    Tim U. Krohne
    Lars-Olof Hattenbach
    Siegfried Priglinger
    Die Ophthalmologie, 2024, 121 (6) : 452 - 461
  • [46] Ocriplasmin zur Behandlung der symptomatischen vitreomakulären Traktion mit und ohne MakulaforamenErste klinische ErfahrungenOcriplasmin as a treatment option for symptomatic vitreomacular traction with and without macular holeFirst clinical experiences
    M. Maier
    S. Abraham
    C. Frank
    N. Feucht
    C.P. Lohmann
    Der Ophthalmologe, 2015, 112 (12): : 990 - 994
  • [47] Aktuelle Trends bei der Behandlung rhegmatogener Netzhautablösungen und perioperative Lagerungsstrategien in Deutschland: Ergebnisse einer retina.net-UmfrageCurrent trends in the treatment of rhegmatogenous retinal detachment and perioperative positioning strategies in Germany: results of a retina.net survey
    Piotr Strzalkowski
    Alicja Strzalkowska
    Andreas Stahl
    Alexander K. Schuster
    Sema Kaya
    Mathias Roth
    Tim U. Krohne
    Robert P. Finger
    Friederike Schaub
    Stefan Dithmar
    Carsten Framme
    Armin Wolf
    Martin Spitzer
    Hansjürgen Agostini
    Nicolas Feltgen
    Oliver Zeitz
    Julian Klaas
    Jost Hillenkamp
    Amelie Pielen
    Horst Helbig
    Salvatore Grisanti
    Hans Hoerauf
    Nikolaos E. Bechrakis
    Peter Walter
    Johann Roider
    Jens Schrecker
    Thomas Ach
    Teresa Barth
    Jan Tode
    Gerd Geerling
    Rainer Guthoff
    Die Ophthalmologie, 2025, 122 (5) : 383 - 392
  • [48] Differences in clinical characteristics and treatment outcomes of submacular hemorrhage caused by age-related macular degeneration and retinal macroaneurysms: A multicenter survey from the Japan Clinical Retina Study (J-CREST) group
    Kimura, Takeshi
    Araki, Takashi
    Yasukawa, Tsutomu
    Kato, Aki
    Kuwayama, Soichiro
    Kinoshita, Takamasa
    Okamoto, Fumiki
    Murakami, Tomoya
    Mitamura, Yoshinori
    Sakamoto, Taiji
    Terasaki, Hiroto
    Kusuhara, Sentaro
    Miki, Akiko
    Takamura, Yoshihiro
    Kondo, Mineo
    Matsubara, Hisashi
    Ueda, Tetsuo
    Tsujinaka, Hiroki
    Gomi, Fumi
    PLOS ONE, 2022, 17 (09):